Patients and physicians may be concerned about starting a biologic treatment during the COVID-19 pandemic. Whether biologics enhance the risk of being infected with SARS-CoV-2 or if the disease course is worsened, remain to be ascertained. So far, no negative signal emerged for an increased risk of severe COVID-19 associated with biologics when compared with the general population.
Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy?
Piaserico, S
;
2021
Abstract
Patients and physicians may be concerned about starting a biologic treatment during the COVID-19 pandemic. Whether biologics enhance the risk of being infected with SARS-CoV-2 or if the disease course is worsened, remain to be ascertained. So far, no negative signal emerged for an increased risk of severe COVID-19 associated with biologics when compared with the general population.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
